Showing results (401-410 of 408) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 408 results.
Lancet (London, England)|September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Ophthalmology|September 22, 2016
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID StudiesJeffrey S Heier, Jean-François Korobelnik, David M Brown, et al.
Ophthalmology|October 3, 2013
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studiesUrsula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, et al.
Ophthalmology|July 23, 2015
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID StudiesDavid M Brown, Ursula Schmidt-Erfurth, Diana V Do, et al.
Acta Ophthalmologica|April 7, 2022
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic careMarc J Sirks, Elon H C van Dijk, Noa Rosenberg, et al.
Ophthalmology|July 12, 2014
Intravitreal aflibercept for diabetic macular edemaJean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, et al.
Ophthalmology|June 15, 2024
International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical TrialsMarko M Popovic, Michael Balas, SriniVas R Sadda, et al.
Pageof 41